NHT has assembled a highly qualified and experienced team to develop the first drug/device therapy product utilizing the DryNeb™ nebulizer. The company’s advisory board of comprises experienced pulmonary drug delivery experts who are knowledgeable in patient care, drug repurposing, drug formulation, device engineering, efficacy, and clinical trials – all important to the platform technology and drug/device product development.